Barclays’s Acrivon Therapeutics ACRV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $58.8K | Buy |
|
|||||
|
2025
Q3 | $36.1K | Sell |
|
|||||
|
2025
Q2 | $24.9K | Sell |
|
|||||
|
2025
Q1 | $66.4K | Sell |
|
|||||
|
2024
Q4 | $229K | Buy |
|
|||||
|
2024
Q3 | $233K | Buy |
|
|||||
|
2024
Q2 | $128K | Buy |
|
|||||
|
2024
Q1 | $152K | Sell |
|
|||||
|
2023
Q4 | $120K | Buy |
|
|||||
|
2023
Q3 | $135K | Sell |
|
|||||
|
2023
Q2 | $185K | Sell |
|
|||||
|
2023
Q1 | $216K | Buy |
|
|||||
|
2022
Q4 | $47.7K | Buy |
|